Use of BCG as an immunostimulant in the surgical treatment of carcinoma of lung: a five-year follow-up report.

Sixty consecutive surviving patients treated with subdermal BCG (5 X 10(6) organisms) have been followed up for five years after resection of lung carcinoma. A control group of the previous 60 consecutive surviving patients not treated with BCG was similarly studied. We found no statistical evidence...

Ausführliche Beschreibung

Bibliografische Detailangaben

Veröffentlicht in:	Thorax
Hauptverfasser:	Edwards, F R, Whitwell, F
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	BMJ Publishing Group 1978
Schlagworte:	Research Article
Online-Zugang:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC470878/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/663885/ https://ncbi.nlm.nih.govhttps://doi.org/10.1136/thx.33.2.250
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!